2-Decanone

2-Decanone

SCHEMBL12491379

CCCCCCCCC(C)=O.CCCCCCCCC(C)=O.CCCCCCCCC(C)=O.CCCCCCCCC(C)=O.O=C1NCCC12CCC1(CC2)OCCO1

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NAAA Q02083 5/20 0.37
▸ FAAH O00519 1/20 0.37
▸ PTPN1 P18031 2/20 0.35
▸ ACP1 P24666 2/20 0.35
▸ CDC25B P30305 2/20 0.35
▸ CYP19A1 P11511 1/20 0.35
▸ GNAI3 P08754 1/20 0.34
▸ GNAO1 P09471 1/20 0.34
▸ GNAI1 P63096 1/20 0.34
▸ KMT2A Q03164 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CCR2 P41597 1/20 0.33
▸ PRKCA P17252 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Nonyl Ketone SCHEMBL28005203 0.67 CES2 (0.62) PTPN1KMT2AMEN1ALDH1A1
SCHEMBL28077374 0.67 CES2 (0.62) PTPN1KMT2AMEN1ALDH1A1
SCHEMBL38665546 0.66 OTUD7B (0.39) —
2-Nonanone SCHEMBL22497634 0.65 CES2 (0.59) PTPN1KMT2AMEN1ALDH1A1
SCHEMBL24005728 0.65 CES2 (0.65) PTPN1KMT2AMEN1ALDH1A1
2-Nonanone SCHEMBL4562318 0.65 CES2 (0.65) PTPN1KMT2AMEN1ALDH1A1
SCHEMBL11144661 0.65 CES2 (0.65) PTPN1KMT2AMEN1ALDH1A1
SCHEMBL21044722 0.65 CES2 (0.65) PTPN1KMT2AMEN1ALDH1A1
2-Tridecanone SCHEMBL19838551 0.65 CES2 (0.65) PTPN1KMT2AMEN1ALDH1A1
2-Dodecanone SCHEMBL23501396 0.65 CES2 (0.65) PTPN1KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2686299-A1 SEC-HYDROXYCYCLOHEXYL DERIVATIVES AS HSL INHIBITORS FOR THE TREATMENT DIABETES F.HOFFMANN-LA ROCHE AG (CH) 2014-01-22 — — EP disclosed
WO-2012123432-A1 SEC-HYDROXYCYCLOHEXYL DERIVATIVES AS HSL INHIBITORS FOR THE TREATMENT DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2012-09-20 — — WO disclosed
Send feedback